Can interferon-gamma and interleukin-10 balance be associated with severity of human Leishmania (Viannia) braziliensis infection?
Autor(a) principal: | |
---|---|
Data de Publicação: | 2007 |
Outros Autores: | , , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Institucional da FIOCRUZ (ARCA) |
Texto Completo: | https://www.arca.fiocruz.br/handle/icict/57016 |
Resumo: | We are grateful to Ms Rosangela Pellegrino for secretarial assistance. This work was supported by Instituto Oswaldo Cruz/FIOCRUZ: internal funds; PAPES/VPPDT/FIOCRUZ, FAPERJ (grant number E-26/170·844/2003), FAPERJ/SUS: Ministério da Saúde and Conselho Nacional de Pesquisa e Desenvolvimento Tecnológico - CNPq (grant number E-26/ 170·614/2005). AMC is a research fellow of CNPq. |
id |
CRUZ_bb33a9332674f39685dcc9cbe1de902b |
---|---|
oai_identifier_str |
oai:www.arca.fiocruz.br:icict/57016 |
network_acronym_str |
CRUZ |
network_name_str |
Repositório Institucional da FIOCRUZ (ARCA) |
repository_id_str |
2135 |
spelling |
Gomes-Silva, A.Bittar, R. de CássiaNogueira, R. dos SantosAmato, V. S.Mattos, M. da SilvaOliveira-Neto, M. P.Coutinho, S. G.Cruz, A. M. da2023-02-11T01:19:59Z2023-02-11T01:19:59Z2007GOMES-SILVA, A. et al. Can interferon-gamma and interleukin-10 balance be associated with severity of human Leishmania (Viannia) braziliensis infection? Clinical and Experimental Immunology, v. 149, p. 440-444, 2007.0009-9104https://www.arca.fiocruz.br/handle/icict/5701610.1111/j.1365-2249.2007.03436.xWe are grateful to Ms Rosangela Pellegrino for secretarial assistance. This work was supported by Instituto Oswaldo Cruz/FIOCRUZ: internal funds; PAPES/VPPDT/FIOCRUZ, FAPERJ (grant number E-26/170·844/2003), FAPERJ/SUS: Ministério da Saúde and Conselho Nacional de Pesquisa e Desenvolvimento Tecnológico - CNPq (grant number E-26/ 170·614/2005). AMC is a research fellow of CNPq.Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Departamento de Imunologia. Laboratório de Imunoparasitologia. Rio de Janeiro, RJ, Brasil.Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Departamento de Imunologia. Laboratório de Imunoparasitologia. Rio de Janeiro, RJ, Brasil.Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Departamento de Imunologia. Laboratório de Imunoparasitologia. Rio de Janeiro, RJ, Brasil.Universidade de São Paulo. Faculdade de Medicina. Divisão Clínica de Moléstias Infecciosas e Parasitárias. Ambulatório de Leishmanioses. São Paulo, SP, Brasil.Fundação Oswaldo Cruz. Instituto de Pesquisa Clínica Evandro Chagas. Rio de Janeiro, RJ, Brasil.undação Oswaldo Cruz. Instituto Oswaldo Cruz. Departamento de Imunologia. Laboratório de Imunoparasitologia. Rio de Janeiro, RJ, Brasil.undação Oswaldo Cruz. Instituto Oswaldo Cruz. Departamento de Imunologia. Laboratório de Imunoparasitologia. Rio de Janeiro, RJ, Brasil.Suitable levels of interferon (IFN)-g and interleukin (IL)-10 seem to favour the outcome of cutaneous leishmaniasis (CL), while high IFN-g and low IL-10 production are associated with severity of mucosal leishmaniasis (ML). Considering that cytokine balance is important for the maintenance of protective responses in leishmaniasis, our aim was to investigate leishmanial antigensinduced IFN-g and IL-10 levels maintained in healed individuals who had different clinical outcomes of Leishmania infection. Thirty-three individuals who recovered from L. braziliensis infection were studied: cured CL (CCL), cured ML (CML), spontaneous healing of CL (SH) or asymptomatic individuals (ASY). Cytokines were quantified by enzyme-linked immunosorbent assay (ELISA) in culture supernatants of L. braziliensis-stimulated peripheral blood mononuclear cells (PBMC). IFN-g levels were higher in CML (7593 5994 pg/ml) in comparison to SH (3163 1526 pg/ml), ASY (1313 1048 pg/ml) or CCL (1897 2087 pg/ml). Moreover, cured ML cases maintained significantly lower production of IL-10 (127 57·8 pg/ml) in comparison to SH (1373 244 pg/ml), ASY (734 233 pg/ml) or CCL (542 375 pg/ml). Thus, a high IFN-g/IL-10 ratio observed in CML can indicate unfavourable cytokine balance. On the other hand, no significant difference in the IFN-g/IL-10 ratio was observed when CCL individuals were compared to SH or ASY subjects. In conclusion, even after clinical healing, ML patients maintained a high IFN-g/IL-10 secretion profile in response to leishmanial antigens. This finding can explain a delayed down-modulation of exacerbated inflammatory responses, which can be related in turn to the necessity of prolonged therapy in ML management. Conversely, lower IFN-g/IL-10 balance observed in CCL, SH and ASY individuals can represent a bettermodulated immune response associated with a favourable prognosis.engBritish Society for ImmunologyCan interferon-gamma and interleukin-10 balance be associated with severity of human Leishmania (Viannia) braziliensis infection?info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleClinical cureIFN-gIL-10Leishmania (Viannia) braziliensisRegulatory immune responsesinfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da FIOCRUZ (ARCA)instname:Fundação Oswaldo Cruz (FIOCRUZ)instacron:FIOCRUZORIGINALGomes-Silva_A_etal_INI_IOC_2007.pdfGomes-Silva_A_etal_INI_IOC_2007.pdfapplication/pdf161737https://www.arca.fiocruz.br/bitstream/icict/57016/2/Gomes-Silva_A_etal_INI_IOC_2007.pdfd403ee197dab80b293a49e42e44d35e6MD52LICENSElicense.txttext/plain1748https://www.arca.fiocruz.br/bitstream/icict/57016/1/license.txt8a4605be74aa9ea9d79846c1fba20a33MD51icict/570162023-09-04 11:30:21.654oai:www.arca.fiocruz.br:icict/57016Tk9URTogUExBQ0UgWU9VUiBPV04gTElDRU5TRSBIRVJFClRoaXMgc2FtcGxlIGxpY2Vuc2UgaXMgcHJvdmlkZWQgZm9yIGluZm9ybWF0aW9uYWwgcHVycG9zZXMgb25seS4KCk5PTi1FWENMVVNJVkUgRElTVFJJQlVUSU9OIExJQ0VOU0UKCkJ5IHNpZ25pbmcgYW5kIHN1Ym1pdHRpbmcgdGhpcyBsaWNlbnNlLCB5b3UgKHRoZSBhdXRob3Iocykgb3IgY29weXJpZ2h0Cm93bmVyKSBncmFudHMgdG8gRFNwYWNlIFVuaXZlcnNpdHkgKERTVSkgdGhlIG5vbi1leGNsdXNpdmUgcmlnaHQgdG8gcmVwcm9kdWNlLAp0cmFuc2xhdGUgKGFzIGRlZmluZWQgYmVsb3cpLCBhbmQvb3IgZGlzdHJpYnV0ZSB5b3VyIHN1Ym1pc3Npb24gKGluY2x1ZGluZwp0aGUgYWJzdHJhY3QpIHdvcmxkd2lkZSBpbiBwcmludCBhbmQgZWxlY3Ryb25pYyBmb3JtYXQgYW5kIGluIGFueSBtZWRpdW0sCmluY2x1ZGluZyBidXQgbm90IGxpbWl0ZWQgdG8gYXVkaW8gb3IgdmlkZW8uCgpZb3UgYWdyZWUgdGhhdCBEU1UgbWF5LCB3aXRob3V0IGNoYW5naW5nIHRoZSBjb250ZW50LCB0cmFuc2xhdGUgdGhlCnN1Ym1pc3Npb24gdG8gYW55IG1lZGl1bSBvciBmb3JtYXQgZm9yIHRoZSBwdXJwb3NlIG9mIHByZXNlcnZhdGlvbi4KCllvdSBhbHNvIGFncmVlIHRoYXQgRFNVIG1heSBrZWVwIG1vcmUgdGhhbiBvbmUgY29weSBvZiB0aGlzIHN1Ym1pc3Npb24gZm9yCnB1cnBvc2VzIG9mIHNlY3VyaXR5LCBiYWNrLXVwIGFuZCBwcmVzZXJ2YXRpb24uCgpZb3UgcmVwcmVzZW50IHRoYXQgdGhlIHN1Ym1pc3Npb24gaXMgeW91ciBvcmlnaW5hbCB3b3JrLCBhbmQgdGhhdCB5b3UgaGF2ZQp0aGUgcmlnaHQgdG8gZ3JhbnQgdGhlIHJpZ2h0cyBjb250YWluZWQgaW4gdGhpcyBsaWNlbnNlLiBZb3UgYWxzbyByZXByZXNlbnQKdGhhdCB5b3VyIHN1Ym1pc3Npb24gZG9lcyBub3QsIHRvIHRoZSBiZXN0IG9mIHlvdXIga25vd2xlZGdlLCBpbmZyaW5nZSB1cG9uCmFueW9uZSdzIGNvcHlyaWdodC4KCklmIHRoZSBzdWJtaXNzaW9uIGNvbnRhaW5zIG1hdGVyaWFsIGZvciB3aGljaCB5b3UgZG8gbm90IGhvbGQgY29weXJpZ2h0LAp5b3UgcmVwcmVzZW50IHRoYXQgeW91IGhhdmUgb2J0YWluZWQgdGhlIHVucmVzdHJpY3RlZCBwZXJtaXNzaW9uIG9mIHRoZQpjb3B5cmlnaHQgb3duZXIgdG8gZ3JhbnQgRFNVIHRoZSByaWdodHMgcmVxdWlyZWQgYnkgdGhpcyBsaWNlbnNlLCBhbmQgdGhhdApzdWNoIHRoaXJkLXBhcnR5IG93bmVkIG1hdGVyaWFsIGlzIGNsZWFybHkgaWRlbnRpZmllZCBhbmQgYWNrbm93bGVkZ2VkCndpdGhpbiB0aGUgdGV4dCBvciBjb250ZW50IG9mIHRoZSBzdWJtaXNzaW9uLgoKSUYgVEhFIFNVQk1JU1NJT04gSVMgQkFTRUQgVVBPTiBXT1JLIFRIQVQgSEFTIEJFRU4gU1BPTlNPUkVEIE9SIFNVUFBPUlRFRApCWSBBTiBBR0VOQ1kgT1IgT1JHQU5JWkFUSU9OIE9USEVSIFRIQU4gRFNVLCBZT1UgUkVQUkVTRU5UIFRIQVQgWU9VIEhBVkUKRlVMRklMTEVEIEFOWSBSSUdIVCBPRiBSRVZJRVcgT1IgT1RIRVIgT0JMSUdBVElPTlMgUkVRVUlSRUQgQlkgU1VDSApDT05UUkFDVCBPUiBBR1JFRU1FTlQuCgpEU1Ugd2lsbCBjbGVhcmx5IGlkZW50aWZ5IHlvdXIgbmFtZShzKSBhcyB0aGUgYXV0aG9yKHMpIG9yIG93bmVyKHMpIG9mIHRoZQpzdWJtaXNzaW9uLCBhbmQgd2lsbCBub3QgbWFrZSBhbnkgYWx0ZXJhdGlvbiwgb3RoZXIgdGhhbiBhcyBhbGxvd2VkIGJ5IHRoaXMKbGljZW5zZSwgdG8geW91ciBzdWJtaXNzaW9uLgo=Repositório InstitucionalPUBhttps://www.arca.fiocruz.br/oai/requestrepositorio.arca@fiocruz.bropendoar:21352023-09-04T14:30:21Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)false |
dc.title.en_US.fl_str_mv |
Can interferon-gamma and interleukin-10 balance be associated with severity of human Leishmania (Viannia) braziliensis infection? |
title |
Can interferon-gamma and interleukin-10 balance be associated with severity of human Leishmania (Viannia) braziliensis infection? |
spellingShingle |
Can interferon-gamma and interleukin-10 balance be associated with severity of human Leishmania (Viannia) braziliensis infection? Gomes-Silva, A. Clinical cure IFN-g IL-10 Leishmania (Viannia) braziliensis Regulatory immune responses |
title_short |
Can interferon-gamma and interleukin-10 balance be associated with severity of human Leishmania (Viannia) braziliensis infection? |
title_full |
Can interferon-gamma and interleukin-10 balance be associated with severity of human Leishmania (Viannia) braziliensis infection? |
title_fullStr |
Can interferon-gamma and interleukin-10 balance be associated with severity of human Leishmania (Viannia) braziliensis infection? |
title_full_unstemmed |
Can interferon-gamma and interleukin-10 balance be associated with severity of human Leishmania (Viannia) braziliensis infection? |
title_sort |
Can interferon-gamma and interleukin-10 balance be associated with severity of human Leishmania (Viannia) braziliensis infection? |
author |
Gomes-Silva, A. |
author_facet |
Gomes-Silva, A. Bittar, R. de Cássia Nogueira, R. dos Santos Amato, V. S. Mattos, M. da Silva Oliveira-Neto, M. P. Coutinho, S. G. Cruz, A. M. da |
author_role |
author |
author2 |
Bittar, R. de Cássia Nogueira, R. dos Santos Amato, V. S. Mattos, M. da Silva Oliveira-Neto, M. P. Coutinho, S. G. Cruz, A. M. da |
author2_role |
author author author author author author author |
dc.contributor.author.fl_str_mv |
Gomes-Silva, A. Bittar, R. de Cássia Nogueira, R. dos Santos Amato, V. S. Mattos, M. da Silva Oliveira-Neto, M. P. Coutinho, S. G. Cruz, A. M. da |
dc.subject.en.en_US.fl_str_mv |
Clinical cure IFN-g IL-10 Leishmania (Viannia) braziliensis Regulatory immune responses |
topic |
Clinical cure IFN-g IL-10 Leishmania (Viannia) braziliensis Regulatory immune responses |
description |
We are grateful to Ms Rosangela Pellegrino for secretarial assistance. This work was supported by Instituto Oswaldo Cruz/FIOCRUZ: internal funds; PAPES/VPPDT/FIOCRUZ, FAPERJ (grant number E-26/170·844/2003), FAPERJ/SUS: Ministério da Saúde and Conselho Nacional de Pesquisa e Desenvolvimento Tecnológico - CNPq (grant number E-26/ 170·614/2005). AMC is a research fellow of CNPq. |
publishDate |
2007 |
dc.date.issued.fl_str_mv |
2007 |
dc.date.accessioned.fl_str_mv |
2023-02-11T01:19:59Z |
dc.date.available.fl_str_mv |
2023-02-11T01:19:59Z |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.citation.fl_str_mv |
GOMES-SILVA, A. et al. Can interferon-gamma and interleukin-10 balance be associated with severity of human Leishmania (Viannia) braziliensis infection? Clinical and Experimental Immunology, v. 149, p. 440-444, 2007. |
dc.identifier.uri.fl_str_mv |
https://www.arca.fiocruz.br/handle/icict/57016 |
dc.identifier.issn.en_US.fl_str_mv |
0009-9104 |
dc.identifier.doi.none.fl_str_mv |
10.1111/j.1365-2249.2007.03436.x |
identifier_str_mv |
GOMES-SILVA, A. et al. Can interferon-gamma and interleukin-10 balance be associated with severity of human Leishmania (Viannia) braziliensis infection? Clinical and Experimental Immunology, v. 149, p. 440-444, 2007. 0009-9104 10.1111/j.1365-2249.2007.03436.x |
url |
https://www.arca.fiocruz.br/handle/icict/57016 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.publisher.none.fl_str_mv |
British Society for Immunology |
publisher.none.fl_str_mv |
British Society for Immunology |
dc.source.none.fl_str_mv |
reponame:Repositório Institucional da FIOCRUZ (ARCA) instname:Fundação Oswaldo Cruz (FIOCRUZ) instacron:FIOCRUZ |
instname_str |
Fundação Oswaldo Cruz (FIOCRUZ) |
instacron_str |
FIOCRUZ |
institution |
FIOCRUZ |
reponame_str |
Repositório Institucional da FIOCRUZ (ARCA) |
collection |
Repositório Institucional da FIOCRUZ (ARCA) |
bitstream.url.fl_str_mv |
https://www.arca.fiocruz.br/bitstream/icict/57016/2/Gomes-Silva_A_etal_INI_IOC_2007.pdf https://www.arca.fiocruz.br/bitstream/icict/57016/1/license.txt |
bitstream.checksum.fl_str_mv |
d403ee197dab80b293a49e42e44d35e6 8a4605be74aa9ea9d79846c1fba20a33 |
bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 |
repository.name.fl_str_mv |
Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ) |
repository.mail.fl_str_mv |
repositorio.arca@fiocruz.br |
_version_ |
1813008841714958336 |